Back

Safety and efficacy of DAPAGLIFLOZIN in patients with systemic right ventricular dysfunction: Preliminary results

15 April 2024 (16:42 - 16:48)
Organised by: Logo
Seminar Presentation Part of: Session 4: Top 5 Abstract Oral Presentations Adult Congenital Heart Disease (ACHD) Open Access EuroACHD 2024 WG on Adult Congenital Heart Disease

About the speaker

Photo
Doctor Mathieu Albertini

Paris (France)

4 More presentations in this session

Presentation thumbnail
A validated mortality score for adults with a Fontan circulation: Fontan Adult Brompton (FAB) score
Doctor A. Arvanitaki (Thessaloniki, GR)
Slides
Presentation thumbnail
Single center experience in treatment of adults with Fontan circulation using Sodium Glucose Cotransporter-2 inhibitors
Doctor P. Skorek (Krakow, PL)
Slides
Presentation thumbnail
A review of more than 2 decades of Heart Lung Transplants at The Freeman Hospital
Doctor A. Henry (Johor Bahru, MY)
Slides
Presentation thumbnail
Risk of heart failure after cancer diagnosis in CHD - patients
Doctor C. Karazisi (Gothenburg, SE)
Slides

Access the full session

Session thumbnail
Session 4: Top 5 Abstract Oral Presentations

The Event

Event poster

EuroACHD 2024

15 April 2024 16:42 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources